Does Dexmedetomidine Decrease the Incidence of Untoward Airway Events After Deep or Awake Extubation in Patients Undergoing Adenotonsillectomy With or Without Myringotomy and Tube Placement?
Phase of Trial: Phase IV
Latest Information Update: 22 Mar 2019
Price : $35 *
At a glance
- Drugs Dexmedetomidine (Primary)
- Indications Sedation
- Focus Adverse reactions
- 14 Mar 2019 Status changed from recruiting to discontinued.
- 07 Mar 2018 Planned End Date changed from 1 Feb 2018 to 1 Feb 2020.
- 07 Mar 2018 Planned primary completion date changed from 1 Feb 2018 to 1 Feb 2020.